<DOC>
	<DOC>NCT00834951</DOC>
	<brief_summary>The purpose of this study is to determine whether the application of low dose total body irradiation following chemo-immuntherapy in elderly patients with aggressive with non-Hodgkin's lymphoma would be safe and potentially benecicial adjuvant therapy</brief_summary>
	<brief_title>Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma, B-Cell</mesh_term>
	<mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
	<criteria>previously untreated, pathology verified aggressive nonHodgkin lymphoma of the diffuse large Bcell type according to the WHO classification. Age between 60 years and 80 years.Positive for an antiCD20 antibody. Good performance status and normal initial normal blood count. Patients with previous lymphoma associated with immune suppression of any sort. Diagnosis or history of indolent lymphoma or other malignancies. Marked impairment of any vital organ such as the heart, lung, liver or kidneys.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Diffuse large B-cell lymphoma</keyword>
	<keyword>Elderly patients</keyword>
	<keyword>Low dose total body irradiation</keyword>
	<keyword>RCHOP14</keyword>
</DOC>